VYALEV (foslevodopa/foscarbidopa solution) is now available in Canada

A new treatment option for advanced Parkinson’s disease, called VYALEV, is now available in Canada. VYALEV is the first 24-hour subcutaneous levodopa-based infusion therapy, designed to manage severe motor fluctuations and dyskinesia without the need for surgery. It offers continuous delivery of levodopa and carbidopa for those whose symptoms are no longer well-controlled by oral medications. This non-invasive therapy provides new hope for people with advanced Parkinson’s, addressing a key unmet need. VYALEV is currently publicly reimbursed in several provinces, with efforts underway to expand access nationwide. Always consult a healthcare provider before adjusting your treatment.